155 related articles for article (PubMed ID: 6797067)
21. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
22. In vitro metabolism of aflatoxin B2 by animal and human liver.
Roebuck BD; Siegel WG; Wogan GN
Cancer Res; 1978 Apr; 38(4):999-1002. PubMed ID: 639051
[TBL] [Abstract][Full Text] [Related]
23. Purified form of cytochrome P-450 from rainbow trout with high activity toward conversion of aflatoxin B1 to aflatoxin B1-2,3-epoxide.
Williams DE; Buhler DR
Cancer Res; 1983 Oct; 43(10):4752-6. PubMed ID: 6411332
[TBL] [Abstract][Full Text] [Related]
24. Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: linear correlation with hepatic cancer risk.
Bechtel DH
Regul Toxicol Pharmacol; 1989 Aug; 10(1):74-81. PubMed ID: 2505337
[TBL] [Abstract][Full Text] [Related]
25. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report.
Lee HS; Sarosi I; Vyas GN
Gastroenterology; 1989 Nov; 97(5):1281-7. PubMed ID: 2551766
[TBL] [Abstract][Full Text] [Related]
26. Tissue specificity of mitochondrial monooxygenase system for aflatoxin B1 activation.
Niranjan BG; Avadhani NG
Biochem Biophys Res Commun; 1980 Jun; 94(3):1021-6. PubMed ID: 6156679
[No Abstract] [Full Text] [Related]
27. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
28. Tissue distribution and hepatic ultrastructural effects of aflatoxin B1 in Japanese quail.
Shanks ET; Statkiewicz WR; Llwelleyn GC; Dashek WV
Pol Arch Weter; 1986; 26(1-2):117-31. PubMed ID: 3111516
[TBL] [Abstract][Full Text] [Related]
29. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
Ramsdell HS; Eaton DL
Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
[TBL] [Abstract][Full Text] [Related]
30. Ovarian function during aflatoxin B1-induced hepatocarcinogenesis in the rat.
Castelli D; Seralini GE; Lafaurie M; Krebs B; Stora C
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):183-94. PubMed ID: 2429351
[TBL] [Abstract][Full Text] [Related]
31. Aflatoxin B1: effect on the synthesis and degradation of mitochondrial proteins in hepatocyte monolayers.
Brookes C; Wright A; Evans PJ; Mayer RJ
Carcinogenesis; 1984 Jun; 5(6):759-65. PubMed ID: 6144403
[TBL] [Abstract][Full Text] [Related]
32. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of a hepatic mitochondrial cytochrome P-450 active in aflatoxin B1 metabolism.
Shayiq RM; Avadhani NG
Biochemistry; 1989 Sep; 28(19):7546-54. PubMed ID: 2514788
[TBL] [Abstract][Full Text] [Related]
34. [Is aflatoxin B1 a hepatic carcinogen in man?].
Franco D; Castaing D; Bréchot C; Morin J
Gastroenterol Clin Biol; 1982 Feb; 6(2):125-8. PubMed ID: 6277718
[No Abstract] [Full Text] [Related]
35. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
Croy RG; Wogan GN
Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC
Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538
[TBL] [Abstract][Full Text] [Related]
37. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver.
Yoshizawa H; Uchimaru R; Kamataki T; Kato R; Ueno Y
Cancer Res; 1982 Mar; 42(3):1120-4. PubMed ID: 6800645
[TBL] [Abstract][Full Text] [Related]
38. Effects of chronic exposure to aflatoxin B1 and aflatoxin M1 on the in vivo covalent binding of aflatoxin B1 to hepatic macromolecules.
Loury DN; Hsieh DP
J Toxicol Environ Health; 1984; 13(4-6):575-87. PubMed ID: 6436500
[TBL] [Abstract][Full Text] [Related]
39. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
Jhee EC; Ho LL; Lotlikar PD
Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
[TBL] [Abstract][Full Text] [Related]
40. Glutathione and aflatoxin-B1-induced liver tumors: requirement for an intact glutathione molecule for regression of malignancy in neoplastic tissue.
Novi AM; Flörke R; Stukenkemper M
Ann N Y Acad Sci; 1982 Dec; 397():62-71. PubMed ID: 6818882
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
